Regulation of Cas9 by viral proteins Tat and Rev for HIV-1 inactivation-Reference-Cited by-同舟云学术

Regulation of Cas9 by viral proteins Tat and Rev for HIV-1 inactivation

Published:2020-08 Issue: Volume:180 Page:104856
ISSN:0166-3542
Container-title:Antiviral Research
language:en
Short-container-title:Antiviral Research

Author:

Vergara-Mendoza Moisés,Gomez-Quiroz Luis E.,Miranda-Labra Roxana U.,Fuentes-Romero Luis L.,Romero-Rodríguez Dámaris P.,González-Ruiz Jonathan,Hernández-Rizo Sharik,Viveros-Rogel Mónica

Publisher

Elsevier BV

Subject

Virology,Pharmacology

Reference45 articles.

1. Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone;Adachi;J. Virol.,1986

2. Trans-activator gene of human T-lymphotropic virus type III (HTLV-III);Arya;Science,1985

3. Human and simian immunodeficiency retroviruses: activation and differential transactivation of gene expression;Arya;AIDS Res. Hum. Retrovir.,1988

4. The challenge of viral reservoirs in HIV-1 infection;Blankson;Annu. Rev. Med.,2002

5. HIV-1 protein expression from synthetic circles of DNA mimicking the extrachromosomal forms of viral DNA;Cara;J. Biol. Chem.,1996

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Strategies for HIV-1 suppression through key genes and cell therapy;Frontiers in Medicine;2023-11-29

2. Intravaginal delivery for CRISPR–Cas9 technology: For example, the treatment of HPV infection;Journal of Medical Virology;2023-02

3. An overview: CRISPR/Cas-based gene editing for viral vaccine development;Expert Review of Vaccines;2022-09-06

4. The CRISPR-Cas system as a tool for diagnosing and treating infectious diseases;Molecular Biology Reports;2022-07-20

5. Application of CRISPR/Cas Genomic Editing Tools for HIV Therapy: Toward Precise Modifications and Multilevel Protection;Frontiers in Cellular and Infection Microbiology;2022-05-25